MetroWest Medical Center-Framingham Union Hospital — Framingham, Massachusetts

MetroWest Medical Center-Framingham Union Hospital is a clinical research site located in Framingham, Massachusetts, United States 01702.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

MetroWest Medical Center-Framingham Union Hospital has participated in 20 clinical trials with 9 currently active.

Therapeutic areas: Breast Cancer, Breast Adenocarcinoma, Hormone Receptor Positive.

Sponsors: SWOG Cancer Research Network, NSABP Foundation Inc, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Framingham

Browse all research sites in Massachusetts · View every site in Framingham

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MetroWest Medical Center-Framingham Union Hospital?

MetroWest Medical Center-Framingham Union Hospital has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MetroWest Medical Center-Framingham Union Hospital conducted?

MetroWest Medical Center-Framingham Union Hospital has 20 clinical trials on record, with 9 currently active. Their work covers Breast Cancer, Breast Adenocarcinoma, Hormone Receptor Positive.

Is MetroWest Medical Center-Framingham Union Hospital accredited by Crixeo Clinical Trials?

MetroWest Medical Center-Framingham Union Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MetroWest Medical Center-Framingham Union Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.